Skip to content

X-Port, ChronoFlex 0605850Recalls & reported problems

Bard Access Systems, Inc. · X-Port Titanium Low-Profile Implantable Port with Attachable 6F ChronoFlex Open-Ended Single-Lumen Venous Catheter Intermediate Kit · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
6
Deaths reported
0
Injuries reported
5
Recalls naming it
0

Summary

The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 00801741026010), received between Oct 18, 2019 and Sep 4, 2025 — classified as 5 injuries, 1 malfunction.

The most frequently reported specific device problem is “Device Appears to Trigger Rejection” (3 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 3 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 1 reportsAug 2025: 0 reportsSep 2025: 1 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520263
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Device Appears to Trigger Rejection3
  • Difficult to Flush3
  • Adverse Event Without Identified Device or Use Problem2
  • Fracture1

Patient problems

  • Infiltration into Tissue3
  • Unspecified Infection2
  • Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1
  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.

  • InjurySep 4, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THROUGH THE LITIGATION PROCESS THAT SOMETIME POST A PORT PLACEMENT, THE PATIENT DEVELOPED WITH UNSPECIFIED INFECTION. THE CURRENT STATUS OF THE PATIENT WAS UNKNOWN.

    Patient problems: Unspecified Infection

    MAUDE report 22961405 ↗
  • InjuryJul 24, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THROUGH LITIGATION PROCESS THAT SOMETIME LATER PORT PLACEMENT PROCEDURE, THE PATIENT DEVELOPED WITH UNSPECIFIED INFECTION. THE CURRENT STATUS OF THE PATIENT WAS UNKNOWN.

    Patient problems: Unspecified Infection

    MAUDE report 22587107 ↗
  • InjurySep 12, 2024Difficult to Flush; Device Appears to Trigger Rejection; Difficult to Flush; Device Appears to Trigger Rejection

    IT WAS REPORTED THAT SOMETIME POST A PORT PLACEMENT, THERE WAS ALLEGEDLY DIFFICULTY IN FLUSHING THE PORT. IT WAS FURTHER REPORTED THAT THERE WAS ALLEGEDLY AN INSTANCE OF MILD INFILTRATION OF INTRAVENOUS FLUIDS. FURTHERMORE, THE PATIENT ALLEGEDLY EXPERIENCED LARGE FIBRIN SHEATH FORMATION AT THE END OF THE PORT AND THE PATIENT WAS TREATED WITH TISSUE PLASMINOGEN ACTIVATOR. REPORTEDLY, THE OUTCOME OF THE ISSUE WAS RESOLVED. THE CURRENT STATUS OF THE PATIENT IS UNKNOWN.

    Patient problems: Infiltration into Tissue

    MAUDE report 20198663 ↗
  • InjurySep 12, 2024Difficult to Flush; Device Appears to Trigger Rejection; Difficult to Flush; Device Appears to Trigger Rejection

    IT WAS REPORTED THAT SOMETIME POST A PORT PLACEMENT, THERE WAS ALLEGEDLY DIFFICULTY IN FLUSHING THE PORT. IT WAS FURTHER REPORTED THAT THERE WAS ALLEGEDLY AN INSTANCE OF MILD INFILTRATION OF INTRAVENOUS FLUIDS. FURTHERMORE, THE PATIENT ALLEGEDLY EXPERIENCED LARGE FIBRIN SHEATH FORMATION AT THE END OF THE PORT AND THE PATIENT WAS TREATED WITH TISSUE PLASMINOGEN ACTIVATOR. REPORTEDLY, THE OUTCOME OF THE ISSUE WAS RESOLVED. THE CURRENT STATUS OF THE PATIENT IS UNKNOWN.

    Patient problems: Infiltration into Tissue

    MAUDE report 20198549 ↗
  • InjurySep 10, 2024Difficult to Flush; Device Appears to Trigger Rejection; Difficult to Flush; Device Appears to Trigger Rejection

    IT WAS REPORTED THAT SOMETIME POST A PORT PLACEMENT, THERE WAS ALLEGEDLY DIFFICULTY IN FLUSHING THE PORT. IT WAS FURTHER REPORTED THAT THERE WAS ALLEGEDLY AN INSTANCE OF MILD INFILTRATION OF INTRAVENOUS FLUIDS. FURTHERMORE, THE PATIENT ALLEGEDLY EXPERIENCED LARGE FIBRIN SHEATH FORMATION AT THE END OF THE PORT AND THE PATIENT WAS TREATED WITH TISSUE PLASMINOGEN ACTIVATOR. REPORTEDLY, THE OUTCOME OF THE ISSUE WAS RESOLVED. THE CURRENT STATUS OF THE PATIENT IS UNKNOWN.

    Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available; Infiltration into Tissue

    MAUDE report 20180400 ↗
  • MalfunctionOct 18, 2019Fracture; Fracture

    THIS REPORT SUMMARIZES ONE MALFUNCTION. A REVIEW OF THE REPORTED INFORMATION INDICATED THAT MODEL 0605850, IMPLANTABLE PORT, WAS ALLEGEDLY FRACTURED DURING TUNNELING. THIS INFORMATION WAS RECEIVED FROM A SINGLE SOURCE. THIS MALFUNCTION INVOLVED A PATIENT WITH NO CONSEQUENCES. THE PATIENT'S AGE, WEIGHT, AND GENDER WERE NOT PROVIDED.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 9208950 ↗

Other PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR devices

All PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page